Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK (2024)

First Author: Dixon G
Attributed to:  EPSRC Hub for Quantitative Modelling in Healthcare funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1183/23120541.00529-2023

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85183625414

Type: Journal Article/Review

Parent Publication: ERJ Open Research

Issue: 1